Literature DB >> 30216198

Noninvasive Administration of Inhaled Epoprostenol and Inhaled Milrinone in Extubated, Spontaneously Breathing Patients With Right Ventricular Failure and Portal Hypertension: A Report of 2 Cases.

Etienne J Couture1,2, Jan-Alexis Tremblay1,2, Mahsa Elmi-Sarabi1,3,4, Yoan Lamarche1,5,4, André Y Denault1,3,4,6.   

Abstract

We describe the cases of 2 patients free from mechanical ventilation after a cardiac surgery with systemic venous congestion from right ventricular (RV) failure. Management of these patients included RV preload reduction with diuretics and RV afterload reduction with inhaled pulmonary vasodilators. Noninvasive combination of inhaled epoprostenol and inhaled milrinone through the AirLife filtered nebulizer system (CareFusion) was used. Reduction of splanchnic venous congestion was assessed by Doppler portal flow pulsatility.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30216198     DOI: 10.1213/XAA.0000000000000886

Source DB:  PubMed          Journal:  A A Pract        ISSN: 2575-3126


  3 in total

1.  Doppler Interrogation of the Femoral Vein in the Critically Ill Patient: The Fastest Potential Acoustic Window to Diagnose Right Ventricular Dysfunction?

Authors:  André Y Denault; Matthew P Aldred; Ali Hammoud; Yu Hao Zeng; William Beaubien-Souligny; Etienne J Couture; Stéphanie Jarry; Caroline E Gebhard; Stephane Langevin; Yoan Lamarche; Pierre Robillard
Journal:  Crit Care Explor       Date:  2020-09-28

Review 2.  Advanced airway management and respiratory care in decompensated pulmonary hypertension.

Authors:  Cyrus A Vahdatpour; John J Ryan; Joshua M Zimmerman; Samuel J MacCormick; Harold I Palevsky; Hassan Alnuaimat; Ali Ataya
Journal:  Heart Fail Rev       Date:  2021-09-02       Impact factor: 4.654

3.  Portal Vein Pulsatility Index as a Potential Risk of Venous Congestion Assessed by Magnetic Resonance Imaging: A Prospective Study on Healthy Volunteers.

Authors:  Osama Abou-Arab; Christophe Beyls; Mouhamed Djahoum Moussa; Pierre Huette; Elodie Beaudelot; Mathieu Guilbart; Bruno De Broca; Thierry Yzet; Hervé Dupont; Roger Bouzerar; Yazine Mahjoub
Journal:  Front Physiol       Date:  2022-04-29       Impact factor: 4.755

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.